| Names | |
|---|---|
| Preferred IUPAC name | 2-aminopentanedioic acid |
| Other names | 2-Aminopentanedioic acid Glutamate Glutamic acid hydrochloride D-Glutamic Acid L-Glutamic Acid |
| Pronunciation | /ɡluːˈtæmɪk ˈæsɪd/ |
| Identifiers | |
| CAS Number | 56-86-0 |
| Beilstein Reference | 13691 |
| ChEBI | CHEBI:18237 |
| ChEMBL | CHEMBL122 |
| ChemSpider | 546 |
| DrugBank | DB00142 |
| ECHA InfoCard | 100.047.453 |
| EC Number | EC 2.6.1.1 |
| Gmelin Reference | 6039 |
| KEGG | C00025 |
| MeSH | D005956 |
| PubChem CID | 611 |
| RTECS number | MN1400000 |
| UNII | 3KX376GY7L |
| UN number | UN1847 |
| CompTox Dashboard (EPA) | DTXSID1023838 |
| Properties | |
| Chemical formula | C5H9NO4 |
| Molar mass | 147.13 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 1.54 g/cm³ |
| Solubility in water | slightly soluble |
| log P | -3.22 |
| Acidity (pKa) | 4.25 |
| Basicity (pKb) | 3.22 |
| Magnetic susceptibility (χ) | -29.5·10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.521 |
| Dipole moment | 6.45 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 86.7 J·K⁻¹·mol⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -1046.6 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | −1561.0 kJ·mol⁻¹ |
| Pharmacology | |
| ATC code | A13AA01 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes serious eye irritation. May cause respiratory irritation. |
| GHS labelling | GHS07, Exclamation mark, Warning |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H319: Causes serious eye irritation. |
| Precautionary statements | Precautionary statements: P261, P264, P270, P271, P272, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362+P364, P501 |
| NFPA 704 (fire diamond) | 1-0-0-W |
| Flash point | 100°C |
| Autoignition temperature | 370 °C |
| Lethal dose or concentration | LD50 oral rat 10,000 mg/kg |
| LD50 (median dose) | 10,000 mg/kg (rat, oral) |
| NIOSH | RA1575000 |
| PEL (Permissible) | 10 mg/m³ |
| REL (Recommended) | 30 mg/kg bw |
| Related compounds | |
| Related compounds | Monosodium glutamate Glutamine γ-Aminobutyric acid α-Ketoglutaric acid Glutamyl dipeptides N-Acetylglutamic acid |
| Product Identification | |
|---|---|
| Product Name | Glutamic Acid |
| IUPAC Name | 2-Aminopentanedioic acid |
| Chemical Formula | C5H9NO4 |
| Synonyms & Trade Names | L-Glutamic Acid; Glutaminic Acid; (S)-2-Aminopentanedioic acid |
| CAS Number | 56-86-0 |
| HS Code & Customs Classification | 2922.42 |
Production of glutamic acid predominantly uses fermentation of carbohydrates by Corynebacterium glutamicum or related strains. In a continuous process operation, the raw material quality, such as the purity of glucose substrate, is central to fermentation yield and downstream impurity burden. Performance of in-process controls on pH, aeration, and temperature drives not only titers but also downstream separation and cost of purification. Process route (fermentation vs. enzymatic or direct chemical synthesis) directly affects typical impurity profiles and allowable limits for amino acid byproducts or unconverted sugars, influencing grade specification for food, feed, or pharmaceutical uses.
Grade specification for glutamic acid is defined by final use: food, feed, or chemical intermediate. Food and pharma grades need refined purification to control microbiological counts and specific elemental impurities; technical grades focus more on total organic impurity load and consistency in assay. Product suitable for pharmaceutical intermediates is typically released only after certifying compliance with monograph requirements, which include controls on heavy metal residues, amino acid content, and optical purity. Production always requires tracing batch records and recording deviations during hydration, crystallization, and drying to ensure batch consistency — a critical concern given the high sensitivity of end users to foreign matter and batch-to-batch performance.
Choice of packaging for glutamic acid responds to hygroscopicity and particle flow — industrial-pack sizes vary from 25 kg paper bags for manual handling to big bags for bulk transfer. The final quality at point of use reflects upstream filtration, crystallization yield, and precision in separation steps, while moisture content and flow properties depend on both drying protocol and humidity management during storage. Adherence to customs and international logistics regulations depends on full alignment with the assigned HS Code 2922.42, covering “Amino-acids and their esters, other than those containing more than one kind of oxygen function; salts thereof: Glutamic acid and its salts.” Accurate product declaration under this code reduces shipping delays and assures correct tariff treatment for each delivery region.
Glutamic acid is typically isolated as a white to nearly white crystalline powder. Some grades may present as crystals or granules depending on process crystallization parameters. Slight softening or color variation can signal process deviation or contamination by colored impurities. Odor is barely perceptible and not considered distinguishing.
Melting behavior varies based on purity and hydration state. Analytical- and pharmaceutical-grade samples exhibit a more precise range, while technical or feed grades may display broader, less reproducible melting points due to trace inorganic residues or organic byproducts from fermentation. Boiling point is not practically observed in production; thermal degradation initiates prior to boiling, giving brown decomposition products detected in off-spec material.
Powder density fluctuates across grades. Bulk density is sensitive to the chosen drying and milling regime, affecting both downstream handling in mixing systems and segregation during packing or transport.
Glutamic acid demonstrates robust chemical stability under standard storage, but prolonged exposure to elevated temperature or humidity encourages Maillard-type browning with amine-containing excipients or upon contact with reducing sugars. Recrystallized material shows highest solution stability, especially when stored below 25°C. Grade variability stems from different stabilization treatments or presence of antioxidant processing aids.
Solubility profile shifts with pH adjustment: at neutral or slight alkali, solubility raises markedly—important for solution preparation in food, pharmaceutical, or bioprocess applications. Industrial feedstocks often require agitation and controlled pH to prevent clumping or precipitation. Feed, food, and pharma grades may be processed with different hydrodynamic protocols to secure uniform dissolution speed and mitigate clump formation.
Specifications are grade-contingent, including pharmaceutical, food, and technical grades. Each application dictates acceptance thresholds for related amino acids, residual sugars, microbial counts, or heavy metals.
| Test Parameter | Pharma Grade | Food Grade | Technical Grade |
|---|---|---|---|
| Purity (as L-Glutamic acid) | Defined by pharmacopeia monographs | Codex-based or customer-specific | Process-validated |
| Impurities | Stringent limit | Intermediate limit | Process-dependent |
| Heavy Metals | Low tolerances | Codex or national standards | Raw-material dependent |
| Moisture Content | Controlled, typically very low | Customer-defined | May have higher residual |
The release standard employs both in-house and regulatory-compliant methods. Parameters may shift with customer auditing practice or final product use-case.
Impurity profile reflects raw materials, fermentation productivity, and downstream purification. Residual sugars, organic acids, biogenic amines, and color bodies should remain within defined process validation data. Close monitoring of trace metals prevents downstream catalytic side reactions during formulation. Each batch undergoes impurity trending to manage process drift and avoid specification creep.
Quality confirmation uses chromatography (HPLC or ion chromatography) for primary component and key impurities. Moisture by Karl Fischer, pH in specified solution, and heavy metals by ICP-OES—method selection aligns with governing monographs or customer contracts. Each method validated for precision, detection limit, accuracy; batch release contingent on meeting all validated specifications.
Raw substrates fall into two major classes: carbohydrates (commonly glucose or starch hydrolysates) for fermentation-based synthesis, and petrochemical intermediates for older chemical routes. Fermentation substrate purity, carbohydrate composition, and amino acid profile affect downstream costs, yields, and typical impurity profile.
Modern industrial practice overwhelmingly favors microbial fermentation, leveraging specific Corynebacterium or Brevibacterium strains genetically optimized for high-yield L-glutamic acid secretion. Certain applications may accept chemically synthesized material, utilizing reductive amination or Strecker synthesis—a route rarely pursued due to racemization and higher impurity burden.
Fermentation is monitored for pH, dissolved oxygen, substrate concentration, and bio-load. Control strategy prioritizes prevention of microbial contamination and off-pathway metabolite formation. Isolated broth undergoes decolorization, filtration, activated carbon treatment, and controlled crystallization. Recrystallization schemes differ by grade: pharma grade requires more stages, especially to eliminate pyrogenic or protein impurities. Purge streams address high-concentration impurity fractions.
Quality control tracks in-process and final-product compliance, using validated analytical methodology. Batch consistency assessment covers purity, identity, microbial status, physical attributes (appearance, flowability), and solution pH. Batch release depends on cumulative compliance—single outlier triggers either rejection or targeted reprocessing.
L-glutamic acid participates in salt formation (notably monosodium glutamate), amide formation to produce glutamine, and esterification for protected derivatives used in peptide synthesis. Decarboxylation produces gamma-aminobutyric acid (GABA) under controlled enzymatic or catalytic conditions.
Reactions often employ mild aqueous solvents and food-compatible mineral acids/bases as catalysts. Temperature control prevents racemization or unwanted decomposition. For amide or ester derivatives, protection/deprotection protocols align with end-use purity and regulatory limits.
Major downstream uses include amino acid supplements, fermentation nutrient blends, biodegradable polymers (via polyglutamic acid intermediates), and specialty flavors or pharmaceutical building blocks. Modification potential expands with controlled condensation or selective substitution chemistries; each route tailored by process economics and end-use compliance.
Material should be kept in cool, dry conditions. Temperature above 30°C or elevated humidity accelerates clumping and can invite degradation via mold growth, especially in open packages or bulk bins. Pharma and food grades require tighter humidity and dust control than technical grades.
Containers constructed from food-grade polyethylene, polypropylene, or lined fiber drums prevent migration of plasticizers or leaching. Metal bins avoided unless lined, since contact with trace acid can trigger corrosion and iron contamination—critical for high-purity applications.
Shelf life depends on purity, packaging integrity, atmospheric protection, and residual moisture. Off-spec yellowing, odor development, caking, or detection of foreign particulates indicate compromised shelf stability. High-purity grades demand evidence of batch retesting if storage exceeds validated periods, typically in line with GMP guidelines.
Classification is grade- and jurisdiction-dependent. Dust hazard exists during handling; pharmaceutical and food grades usually classified as low hazard except for chronic inhalation or significant accidental ingestion in large amounts. Chronic exposure studies required for worker safety assessment in manufacturing and packaging zones.
Operational controls focus on airborne dust suppression, personnel protective equipment (PPE), and local extraction. Skin and eye contact present low but nonzero irritation risk; gloves and goggles are routine precautions. Agencies may request site-specific or customer-driven precautionary measures if used in specialized environments.
Acute oral toxicity is low. Repeated inhalation of dust during bulk transfer and packaging operations calls for risk assessment and engineering controls. Regulatory authorities may issue region-dependent exposure guidelines, which inform production line PPE and safety training.
Specific occupational exposure limits are not universal, but manufacturers implement dust monitoring, HEPA filtration, and closed transfer systems where transfer volumes justify. Standard operating procedures detail cleaning, ventilation, and spill response to mitigate both safety and cross-contamination hazards during batch changeovers.
Glutamic acid production relies on fermentation or acid hydrolysis of suitable carbohydrates and substrates. Facility output depends on the substrate supply chain, fermenter line allocation, processing cycle, and downstream purification staging. Plant flexibility allows for adjustment to seasonal or contract-driven demand, with short-term surges dictated by raw material flow, utility availability, and downstream labor scheduling. In general, technical grade throughput scales higher than food or pharmaceutical grades, as stricter controls and documentation slow release for elevated grades. Surge capacity allocation for annual tenders or market disruptions factors heavily in the production run schedule.
Prompt shipments depend on raw material reserve, fermenter line occupation, and purification stage bottlenecks. Lead times typically tighten for standardized grades, with variance in specialty grades or custom packaging. Food and pharma grades invoke longer QC review cycles. MOQ reflects production lot sizes, transit cost efficiency, and shrink control on higher-purity or low-turnover grades. Standard practice sets MOQ from a single pallet for technical grade up to custom volume for validated lots or specialty packaging.
Packaging spans industrial bulk bags, multi-wall paper sacks, fiber drums, or customized barrier liners, each chosen per grade and regulated application. Pharma-grade mandates tamper-evident, traceable units under GMP environments. Food grade often requires moisture-barrier secondary film to avoid caking or contamination. Technical grade relies on bulk units for downstream industrial blending. Packaging form correlates with internal packaging validation, logistic efficiency, and customer dock handling capacity.
Shipping terms align with global INCOTERMS standards, supported by logistics partners familiar with bulk and specialty chemical handling. Documentation and pre-shipment compliance, especially for food, feed, or pharma grades, factor into the final lead time. Payment expects standard credit terms, with L/C or advance payment for first orders or high-value batches. Regulatory requirements from destination markets—especially import certifications and customs documentation—require coordinated QC release and document filing.
Production cost tracks major input classes: carbohydrate feedstock, fermentation nutrients, utilities, and process water. The primary influence is the cost of carbohydrate substrates, which fluctuate with agricultural cycles, transportation, and market speculation. Food and pharma grades require higher-purity reagents, adding cleaning, validation, and documentation costs. Utility spikes during high-energy fermentation cycles drive incremental cost increases, especially in markets with variable energy rates or water stress.
Price instability most often stems from substrate market swings—corn, sugar, and starch are dependent on agricultural yields, extreme weather events, storage, export controls, and regional policy changes. Fermentation nutrient costs, especially for nitrogen sources, also introduce price movement. Utility shortages, feedstock rationing, labor disruptions, and unplanned line outages contribute to short-term supply tightness. Energy price volatility ripples through facility operating costs. Regulatory events, such as new environmental standards or audits, add compliance surcharges and documentation fees.
Product grade forms the most significant price determinant after raw material base cost. Technical grade sells at a discount, reflecting relaxed impurity thresholds, minimum documentation, and bulk packaging. Food grade requires additional production runs, segregation, and validated traceability, passing extra cost to the end user. Pharmaceutical grade commands premium pricing due to multi-step purification, risk assessment, and batch-specific CoA, with validation and release costs factored in. Packaging, particularly for export, introduces further cost increment based on compliance with international shipping, labeling, and anti-tamper standards.
Grade directly determines specification limits for heavy metals, solvents, residuals, and bioburden—higher certification means more intensive purification and in-process control. Purity over 99% requires additional chromatographic separation, longer QC turnaround, waste management, and batch rework for any deviation. Special packaging must protect against moisture ingress, cross-contamination, and tampering, increasing unit cost on certified lots. Country-of-origin documentation and relevant certifications also add to per-tonne or per-package pricing, especially under FDA or EFSA frameworks.
Glutamic acid faces demand from animal nutrition, food enhancement, and pharmaceutical precursor markets. Exportable supply depends on regional production capacity, import/export policy, and local feedstock cost structure. Inventory tightness reflects either local surpluses or global logistics congestion, as well as end-user pivoting to alternate amino acids or synthetic flavors amid price surges.
North American output emphasizes technical and food-grade product, with consistent demand from food processing and animal feed sectors. The EU prioritizes food and fine chemical applications, with regulatory compliance driving up cost for certified grades. Japan operates under high technical standards, focusing on high-purity and specialized markets, with stable but mature consumption. India’s market reflects dynamic capacity expansion, low cost base, but exposure to agricultural volatility. China leads global output, anchoring cost leadership through scale, but subject to shifting environmental regulation, local raw material rationing, and periodic port disruptions. Cross-border trade sensitivity grows with geopolitical and compliance uncertainty.
Forecasts project stable baseline demand from food and feed, with modest growth in biotechnological and pharmaceutical applications. Anticipated substrate price volatility will drive short- to medium-term price lifts, especially under adverse agricultural cycles or geopolitical stress. Grade-specific differentials will persist, widening for certified segments with additional compliance layers. Shifts in environmental regulation, especially in major producing regions, may introduce cost inflation at the production and export stages. Data reflect collation of recent industry releases, producer quarterly results, and public export-import records.
Price forecasts and supply insights rely on public market reports, direct manufacturer production bulletins, export customs records, and third-party market analytics. Regional raw material cost modeling is based on prevailing agricultural statistics, feedstock indexes, and regulatory updates from official bodies.
Production diversification and realignment have accelerated in light of ongoing supply chain challenges since 2022. Manufacturers are pursuing alternative substrates and integrating renewable energy to buffer against raw material price shocks. Capacity expansions in South Asia and ongoing environmental upgrades in East Asia directly impact market tightness and spot market volatility.
Risk-based frameworks for impurity controls and documentation for food/feed applications in the EU and US have raised operating costs. China’s environmental enforcement has led to facility suspensions, export backlog, and supply rerouting. New labeling and provenance mandates in international trade introduce compliance checkpoints that extend production and release cycles, impacting just-in-time supply models.
Producers are tuning batch campaign logic, timing raw material purchases to crop cycles, and investing in in-line analytics to preempt non-conformance and batch failures. Dual-source strategies on substrates, pre-negotiated logistic slots, and flexible production windowing are being deployed to absorb market shocks. Reactive mitigation includes hedging of input commodities and lean inventory deployment at target export docks.
From our experience in large-scale fermentation and downstream recovery, industrial glutamic acid finds its primary use in:
| Application | Preferred Grade | Critical Quality Attributes |
|---|---|---|
| Food/Feed Additives | Food Grade, Feed Grade | Low biogenic amines, low heavy metals, defined microbial limits |
| Pharmaceutical/Nutritional | Pharma Grade | Purity above 99%, strict residual solvent and endotoxin controls, batch-level traceability |
| Biotech Fermentation | Bio-Industrial Grade | Amino acid profile, bioburden management, consistent solubility |
| Chemical Synthesis | Technical Grade | Process-specific impurity profile, compatibility with solvents/reagents, handled as per downstream sensitivity |
Grade-specific parameters undergo continuous monitoring and adjustment. For food/pharma, heavy metal and microbial content receive high attention through validated analytical protocols. Biotech customers will notice batch performance depends on not only purity but also the presence or absence of certain trace metabolites or fermentation by-products. In technical and industrial segments, cost-performance tradeoffs often guide tolerance to residuals, favoring throughput and stability above absolute chemical purity.
Clearly articulate the functional role in your end-use case: direct consumption, ingredient/filler, synthesis precursor, or process reagent. Misidentification at this stage multiplies complications downstream, especially in regulated environments.
For all ingredients entering regulated markets, determine if codex, pharmacopeial, or local food/feed law applies. We audit against these, but variance exists regionally and by end-use. Declaration of intent allows for matching batch release documentation and pre-clearance auditing.
Align purity grade with tolerance to common impurities such as biogenic amines, residual solvents, fermentation by-products, and inorganic salts. Technical grades tolerate broader spec. Pharma and food-grade lines receive additional analytical scrutiny, cleaning validation, and cross-batch contamination checks.
Bulk industrial buyers usually seek cost leverage, accepting broader specifications. Strict applications—injectables or infant nutrition—require smaller lots released under exhaustive controls and replicate analyses, which influences both cost and delivery logistics.
Confirming grade suitability under actual use conditions often exposes subtle incompatibilities or performance differences. Sample evaluation under end-use formulation and process recapitulates the true industrial environment and reveals whether there is a need for tighter specs or process adjustment. For critical supply chains, we recommend joint quality workshops and custom release protocols.
As the manufacturer, we implement multi-tier quality management systems that follow internationally recognized standards. Each production site operates an internal quality control system calibrated to ISO-based protocols. For pharmaceutical and food grades, certified management programs structure every batch from incoming raw material assessment to finished goods release. Audits and re-certification cycles define control effectiveness and uncover process improvement opportunities.
Grade selection drives the range of certifications supplied. Industrial, food, and pharmaceutical grades each rely on tailored compliance matrices. Regulatory bodies and end-use industries dictate requirements such as food additive registration, GMP for pharmaceutical use, and Kosher or Halal documentation when the application requires. Each certificate ties to its corresponding batch with traceable documentation maintained in facility records.
Each order receives a dedicated package including Certificates of Analysis, detailed batch records, and, where requested, Residual Solvent Reports or Allergen Statements. Full traceability starts from raw material sourcing and continues through each production stage. The certificate structure aligns with the final destination’s regulatory landscape and the user’s specification sheet. Batch-to-batch consistency is documented using defined release specifications rather than default or generic test lists.
Our installed production lines are sized to back sustained, multi-year project demands. Industrial and food grade allocation adjusts based on annual forecast cycles, supported by local and export market data. Flexible volume agreements accommodate both short-term campaign requirements and long-term partnership models, responding to project ramp-up and market volatility. Operations scheduling includes capacity buffers to absorb demand swings or logistic interruptions.
Raw materials are sourced on volume-based contracts with upstream partners who meet our qualification audits. Alternate sourcing routes support business continuity for regionally variable supply chains. Quality and process teams maintain in-process controls designed to ensure key impurity profiles remain stable between campaigns. Manufacturing redundancy and modular line setup allow rerouting of core steps if unplanned downtime threatens continuous supply.
Application for product samples follows a qualification flow involving technical use disclosure, required certification type, and batch-size requirements. Each sample release comes from a full production batch, carrying the same analytical and regulatory documentation as commercial shipments. Special grade sampling—such as pharmaceutical intermediates or food additive specialties—triggers internal review and parallel documentation updates, ensuring that trial material aligns with the relevant regulatory framework.
Partnership frameworks start with customer-driven volume projections and critical-to-quality (CTQ) parameter mapping. Our supply team builds procurement models supporting both Make-to-Stock and Make-to-Order delivery based on the customer’s project needs, supply chain risk tolerance, and specification stringency. Production sequencing adapts to evolving forecasts, while stock reservation and call-off agreements reduce order cycle times. Every model is grounded in technical feasibility as verified by site-level QA, continuous improvement metrics, and real-time inventory management.
Research departments across the glutamic acid sector focus heavily on process efficiency and raw material optimization. Fermentation remains the core approach, and strain improvement receives consistent investment. Selection of fermentation strains often targets higher productivity and reduced by-product formation based on application requirement—food, pharmaceuticals, industrial. Each application segment demands a different level of purity, making process adjustment routine. Recent industry-driven efforts also target the reduction of carbon input, specifically for facilities running on grain starch hydrolysates or cane derivatives.
Traditional demand in food and feed is well established, but material scientists now review glutamic acid’s potential as a platform chemical for biodegradable polymers, particularly polyglutamic acid applications and bio-based solvents. Growth in bioplastics and migration toward non-petroleum-derived intermediates shape the long-term application mix. Some clients working in pharmaceuticals request special grades for injectable use or as excipient, placing higher scrutiny on residuals, enantiomeric purity, and microbial load.
Batch consistency continues to challenge plants with broad feedstock variability or where water quality control is a problem. Impurity removal, especially low-level residual sugars, organic acids, and fermentation by-products, still draws process innovation. Where continuous fermentation is deployed, fouling, foam management, and downstream harvest bottlenecks require both monitoring and operator training. A significant breakthrough includes enzymatic decarboxylation steps aimed to boost L-isomer concentration without costly downstream racemate separation. Plants that have integrated high-efficiency filtration or membrane bioreactors see gains in both yield and batch purity.
Clients in food and feed remain consistent buyers, but market growth is increasingly set by expansion in performance polymer and specialty chemical sectors, especially in regions supporting local bio-based chemicals. Production capacity adjustments will follow regional regulatory shifts on raw material origin and GMO strain acceptance. Output in Asia-Pacific and South America will likely track downstream demand for feed-grade and industrial applications.
Fermentation technology will continue to evolve through digital process control, online monitoring for impurity spikes, and data-driven yield management. Intake logistics, quality protocols for starch-based substrates, and water use will define competitive advantage, especially where water treatment and recycling are essential. The move toward zero-liquid-discharge in waste management offers both economic and environmental benefit for large-scale plants; smaller producers usually adopt shorter process chains for simplicity but face greater batch variability risk.
Chemical manufacturers with integrated waste valorization—such as conversion of by-product biomass for on-site energy—see lower net emissions per unit output. Process teams evaluate all inputs for biodegradability; plant design now typically incorporates lifecycle assessment. Final grade and application dictate allowable input sources and process aids—particularly for European and North American clients adhering to advanced sustainability certification standards.
Manufacturing teams respond to client queries regarding suitability of grade for process integration, with service engineers able to advise on issues such as downstream compatibility, impact of impurity profile on formulation, or blending requirements for batch versus continuous use. Requests for custom grade development—higher purity, alternate crystal forms, or specific particle size—are handled by project scaling teams and are subject to validation through both in-house quality and client-side assessment procedures.
For polymer production and highly regulated markets requiring documentation of impurity thresholds, technical teams supply process adjustment recommendations. Many industrial users work with application engineers to address solubility, dispersibility, or the effect of pH on subsequent processing. For feed or food use, on-site technical visits are scheduled to troubleshoot dosing or storage management; plant personnel evaluate any reported inconsistencies to trace root cause back to either grade choice or warehousing conditions.
All industrial shipments are backed by technical after-sales service, with batch documentation fully accessible. Feedback on out-of-spec deliveries or in-process failures prompt immediate manufacturing investigation—review of raw material batches, production run logs, and analytical controls. Corrective actions depend on traceability protocols, and, where applicable, client-provided retention samples. The release standard is defined by internal quality control aligned to each contract’s technical agreement.
Each production batch of glutamic acid comes from our own process lines, controlled by factory teams with years of operational experience. We oversee fermentation, purification, and crystallization, with documented traceability for every lot. Glutamic acid leaves our facility after extensive internal checks for purity and assay, as confirmed by routine HPLC and moisture analysis. No outside procurement means every kilogram reflects our facility standards.
Our glutamic acid contributes to industrial formulations beyond food and feed. Sectors such as pharmaceuticals, biodegradable plastics, and electroplating plants rely on its chemical consistency. Manufacturers of resins and specialty polymers incorporate our material for predictable downstream reactions. When clients specify technical-grade glutamic acid for specialty coatings or extractants, our material delivers the exact lot-to-lot characteristics their blended processes require.
Quality programs rest on process discipline, real-time analytics, and physical inspections. Automated sampling covers physical attributes and chemical profile throughout the production run. Analytical chemists log every adjustment, and only compliant batches advance to final packaging. The approach supports customer certification audits and third-party lab requests. This minimizes production interruptions or batch failures at our buyers’ facilities.
Packing lines accommodate bulk bags, high-strength kraft paper sacks, or custom tote bins. Storage warehouses handle weather-protected inventory, supported by tracked logistics for on-time shipments to industrial hubs and regional distribution centers. Our team coordinates bulk release and documents every transfer from storage to loading dock, controlling both speed and documentation accuracy. We allocate finished inventory for contract customers and can support volume scale-ups to meet extended project schedules.
Technical questions go directly to engineers and chemists active on the production floor. Our staff discusses integration with industry clients—whether for reaction process optimization, new product sampling, or raw material handling advice. This real-time support helps manufacturing engineers resolve batch compatibility, dosing procedures, or filtration adjustments that differ from basic application guidelines.
Control over production delivers value to manufacturers, procurement teams, and distributors. Clients reduce sourcing risks by buying at the source, with documented product history and direct access to the factory’s knowledge. Our in-house expertise helps manufacturers avoid downtime, quality claims, and inconsistent sourcing—factors that impact production costs and schedule confidence across full contract cycles.
Manufacturing glutamic acid at scale means establishing reproducible chemical standards and ensuring every shipment aligns with customer requirements across foods, pharmaceuticals, and technical applications. Our production sites implement rigorous controls with raw material selection and continuous in-process verification. Typical purity for food-grade glutamic acid remains above 99%. Stringent filtration, precipitation, and drying methods back up this purity range. Each batch undergoes final confirmation by high-precision techniques like HPLC or titration before release.
Producing high-purity glutamic acid begins with fermentation using specific microbial strains, paired with carefully monitored feedstocks. Our technical team closely monitors variables such as pH, temperature, and oxygen to optimize yield and minimize by-products. After fermentation, multiple stages of clarification, decolorization, and crystallization isolate glutamic acid. Steps include double crystallization and filtration, which effectively remove proteins, salts, and residual by-products. These controls minimize contaminants such as arsenic, lead, and heavy metals, keeping results well within limits set by international food-grade or pharmaceutical regulations.
Our reference specifications generally set moisture below 0.2% and chloride not exceeding 0.1%. Typical sulfate values come in significantly lower than the maximum 0.05% allowed in food applications. Other residual elements—like ammonium or phosphate—reflect levels well beneath safety thresholds. Glutamic acid content consistently meets or exceeds 99% on a dry basis. Levels of insoluble materials and loss on drying are monitored tightly, thanks to process improvements developed by our engineering teams working directly in the plant.
Every lot is backed by a certificate matching the actual measured values, not just a theoretical range. Our laboratory measures optical rotation, further confirming product identity and quality. Microbiological testing also plays a central role in our food and pharmaceutical lines. We rigorously check for common organisms such as Salmonella and E. coli. Only lots passing these critical points ship to customers.
Clients in the pharmaceutical field often request even tighter impurity profiles and further analytical documentation. Our protocol allows us to implement additional purification and provide lower endotoxin specifications when required for advanced drug manufacturing. On the industrial side, technical grades are manufactured to balance cost-efficiency and quality, with chloride and sulfate controls adjusted accordingly.
Standard packaging ranges from multi-layer bags for food and feed to bulk containers for industrial use. Each is designed to minimize contamination during transport and storage. Labeling clearly states batch numbers, production dates, and compliance with regulatory standards. We conduct stability studies, simulating real-world storage conditions, to guarantee shelf life supports our clients’ supply chain planning.
Extensive technical dossiers and regulatory support are available for audit and qualification needs. Our production records hold the details needed for full traceability from raw material to finished product. Continuous investments in automation, staff training, and validated cleaning protocols help us deliver quality consistently across every lot. As direct manufacturers, we prioritize efficiency, transparency, and reliability for all our glutamic acid deliveries, recognizing our role as a foundational source in the supply chain.
Glutamic acid stands as one of the core amino acid ingredients we produce at industrial scale. Every lot rolling off our production line represents real planning, resource commitment, and a clear understanding of what meets our customers’ manufacturing or formulation needs. Over the years, we've worked with procurement officers, plant managers, R&D chemists, and contract manufacturers. All of them approach us with practical questions about order sizes and how our packaging helps them reduce waste, maximize efficiency, and comply with internal protocols or regulatory rules.
On our shop floor, efficiency shapes every run. Large-scale fermentation and downstream processing require careful batching and storage discipline. These technical realities drive our minimum order quantity (MOQ) policy. For glutamic acid, we start commitments at one metric ton per order. This threshold aligns with the realities of both our production economics and the needs of downstream users who depend on consistent quality and tight spec control. A single metric ton batch reflects the volume at which material handling, quality checks, and logistics deliver value for both sides. Many industries, from food processing to chemical synthesis, use far more per run, but this benchmark protects our customers from inconsistent quality and keeps pricing competitive.
On the packaging side, we keep options straightforward and robust. Our primary packaging for glutamic acid centers on 25 kg multi-layered kraft paper bags with inner PE linings. This format protects the product against moisture and contamination—a must for an amino acid that will often see direct contact with sensitive food, pharmaceutical, or tech processes. Our packaging comes palletized by default, with 40 bags (1,000 kg) securely stretch-wrapped for transit stability. Our materials handling team inspects each pallet for seal integrity and labeling to match shipment documentation.
For bulk buyers and automated plant delivery, we supply 500 kg and 1,000 kg FIBCs (bulk bags), designed for direct discharge into silos or large-scale dosing systems. This approach reduces handling time, limits exposure risk, and supports high-throughput operations. Secure strapping and inner lining options protect sensitive cargo from transit hazards or facility environments with high humidity.
A few partners approach us with niche requirements: customized packaging, non-standard batch sizes, or labeling to comply with global shipping rules. Our technical and logistics team reviews these cases in person, evaluating safety, feasibility, and practical implications for processing lines and end-use. Not every non-standard package fits our handling systems, but we have prototyped tamper-evident liners, smaller sample packs for R&D, and translated labels for multinational shipments where international compliance rules apply.
We have invested in direct feedback loops with our users, learning from each pallet, FIBC, and custom run that leaves the plant. Glutamic acid is often the foundation of a formulation, and predictable quality begins with consistent handling and clear logistics. Providing clarity about minimum batch size and packing options sets both sides up for success. Our team stands ready to support further documentation needs, certificate requests, and technical details to help integrate our product into any system or regulatory framework.
As the direct manufacturer of glutamic acid, we carry full responsibility for ensuring that every batch leaves our factory in compliance with global import and export standards. Navigating international trade regulations has become more critical than ever with tightening controls across continents. We deal directly with regulatory authorities, keep up with new documentation requirements, and maintain traceable records for every shipment.
Regulatory compliance forms the backbone of our operations. Authorities worldwide classify glutamic acid under specific customs codes and require strict adherence to purity, labeling, and safety protocols. The HS (Harmonized System) code must match destination regulations. For most regions, this product is not considered hazardous, but each jurisdiction defines chemical categories, so we confirm legal status before shipment. The European Union, North America, and Asia have their own sets of REACH, TSCA, and chemical inventory requirements, and our compliance team tracks updates continuously.
We register our product according to destination country laws, with supporting Quality Assurance systems audited annually. Pre-shipment testing includes batch-specific analysis certificates. We use analytical data from our in-house laboratory to prove compliance with recognized food or industrial specifications. These certificates are available to all our buyers and to customs officials upon request, supporting smooth border clearance and reducing inspection times.
Our export managers prepare complete documents for each consignment. The set includes:
Certain markets, especially in the Middle East and South America, might request embassy attestation or legalized documents. We arrange such requirements well ahead of departure through our experience and established relationships with trade authorities.
Customers have raised concerns about contamination or damage in transit. So, our logistics team works with trusted carriers and uses our standard packaging system: food-grade lined Kraft paper bags or high-density polyethylene drums. Every package features tamper-evidence and full batch traceability. Before shipping, inspectors review each consignment on our loading bay for conformity, and we upload inspection photos into secure internal records, supporting dispute resolution and insurance claims.
Discrepancies can occur at customs due to missing or inconsistent documentation. Our solution centers on a digital system for managing paperwork—every export document is generated together with QR-coded links to original test reports and safety papers. These are accessible to authorities in real time, which minimizes miscommunication and speeds up clearance.
Import and export regulations constantly evolve. Our compliance and logistics specialists attend seminars and international forums focused on chemical product trade. Every member is trained to update documentation and procedures rapidly in response to new rules, keeping client shipments on schedule. If any issue arises at the border, our logistics team responds directly with corrections or supplementary paperwork, preventing shipment delays or product recall.
We consider the safe and compliant global movement of glutamic acid a key part of our manufacturing value. Direct control over documentation, batch quality, and shipping translates into lower risk and fewer surprises for all international partners relying on us for uninterrupted supply.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales3@ascent-chem.com, +8615365186327 or WhatsApp: +8615365186327
